Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20151
20161
20171
20202
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Novartis Pharmaceuticals3
Amsterdam UMC, location VUmc1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Bayer1
Exelixis1
Joachim Aerts, MD PhD1
The Netherlands Cancer Institute1
University Medical Center Groningen1
Var2 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms14
Triple Negative Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Neoplasms3
Stomach Neoplasms3
Esophageal Neoplasms2
Esophageal Squamous Cell Carcinoma2
Glioblastoma2
Ovarian Neoplasms2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.